Inpharmation Ltd

Pricing and market access is at the core of what we do. Our toolkit of predominantly quantitative solutions is evidence-based and tailored specifically for pharma pricing and market access research:

• Early pricing and market access assessments

Award winning models which predict price-response based on payer behavior rather than what payers say in interviews. We quantify what’s driving the value-based price your product can achieve more efficiently than alternative techniques.

• Launch pricing and market access strategy development

Our pharma-validated solutions have been deployed in more than 200 projects. We use primary research techniques that produce unbiased estimates of price-response and connect price to access and demand.

• Innovative contracting simulation

More than 25 years of forecast modeling experience has enabled Inpharmation to develop a powerful innovative contracting simulator. The simulator handles the uncertainties you face when designing innovative contracting agreements.

• International reference pricing and country launch sequence optimization

Inpharmation’s IRP simulator was the first mover – developed more than 15 years ago. Clients return to us year after year because of our expert support and to maintain access to our detailed reference pricing rules database.

All top 10 pharma use our solutions. People choose to work with us because of the depth and breadth of our experience and our hands-on approach to every project. We work in all major and developing countries; all stages of the product life cycle; all therapeutic areas, from rare to mass market; and all levels of product innovation, from ultra-innovative cell and gene therapies to me-too’s.
Your products have years of research to prove their value. So do ours.
Speak to our experts at booth 39 to find out how we can solve your pricing needs.